Butterfly Network (BFLY) EBT Growth (1y) (2021 - 2026)
Butterfly Network (BFLY) EBT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 74.66% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -27.02% |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 103.34% |
| 10 | Butterfly Network | 1.72 Bn | 1.58 Bn | 18.29 Mn | 9.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.19% |
| Dec 31, 2025 | 16.40% |
| Sep 30, 2025 | -101.32% |
| Jun 30, 2025 | 11.95% |
| Mar 31, 2025 | 35.84% |
| Dec 31, 2024 | 58.72% |
| Sep 30, 2024 | 38.37% |
| Jun 30, 2024 | 45.29% |
| Mar 31, 2024 | 34.96% |
| Dec 31, 2023 | -30.81% |
| Sep 30, 2023 | 49.98% |
| Jun 30, 2023 | 19.85% |
| Mar 31, 2023 | 24.76% |
| Dec 31, 2022 | -116.42% |
| Sep 30, 2022 | -303.38% |
| Jun 30, 2022 | -1,137.56% |
| Mar 31, 2022 | -6,575.68% |
| Dec 31, 2021 | 32.05% |
| Sep 30, 2021 | 85.29% |
| Jun 30, 2021 | 87.56% |